Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2010 / Cilt: 56 - Sayı: 4

Anti-TNF-α ve geleneksel tedavi alan romatoid artritli hastalarda serum sialik asit ve oksidatif stres parametrelerinin değerlendirilmesi

Assessment of serum sialic acid and oxidative stress parameters in rheumatoid arthritis patients receiving anti-TNF-a and conventional therapies

Pages
182–185
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Turk J Phys Med Rehab 2010;56:182-5.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to evaluate sialic acid (SA) levels and oxidative stress parameters by measuring nitric oxide metabolites (NOx), thiobarbituric acid-reactive substances (TBARS) and thiol (SH) in rheumatoid arthritis (RA) patients treated with either conventional or anti-tumor necrosis factor-a (anti-TNF-a) therapy.
📊
Key Findings & Data:Materials and Methods: Eighty-six RA patients and 20 healthy controls were enrolled in the study.
💡
Conclusion & Impact:Turk J Phys Med Rehab 2010;56:182-5.
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to evaluate sialic acid (SA) levels and oxidative stress parameters by measuring nitric oxide metabolites (NOx), thiobarbituric acid-reactive substances (TBARS) and thiol (SH) in rheumatoid arthritis (RA) patients treated with either conventional or anti-tumor necrosis factor-a (anti-TNF-a) therapy. Materials and Methods: Eighty-six RA patients and 20 healthy controls were enrolled in the study. All RA patients fulfilled the American College of Rheumatology (ACR) criteria for RA. Thirty patients were on anti-TNF-a therapy. The rest of the patients were either treated with two or three disease-modifying anti-rheumatic drugs. Health Assessment Questionnaire (HAQ) score and the Disease Activity Score 28 (DAS28) were calculated in all patients. NOx, TBARS, SA, and SH levels were measured in both patients and controls.Results: The SA levels were statistically higher in RA patients than in controls. We found increased levels of TBARS and NOx and decreased levels of SH in both groups, but these results were statistically insignificant. Spearman correlation analysis revealed positive correlation between serum TBARS levels and both NOx (r=0.322, p=0.001) and SA (r=0.242, p=0.017) levels.Conclusion: Our results confirm the role of SA in the pathogenesis of RA and its correlation with oxidative stress. Further studies on larger numbers of subjects and with longer treatment durations are needed to analyze the long-term effects of RA therapies on serum oxidative stress parameters. Turk J Phys Med Rehab 2010;56:182-5.

Özet

Amaç: Bu çalışmada geleneksel veya anti-TNF-a tedavisi alan romatoid artrit (RA) hastalarında nitrik oksit metabolitleri (NO), tiobarbitürik asit türevi aktif maddeler (TBARS) ve tiyol grupları (SH) ölçümü ile oksidatif stres ve sialik asit (SA) düzeylerini değerlendirmeyi amaçladık.Gereç ve Yöntem: Çalışmaya 86 RA hastası ile20 sağlıklı kontrol dahil edildi. RA hastalarının tümü, RA için ACR kriterlerini karşılamaktaydı. Otuz hasta anti-TNF-a tedavisi alıyordu. Diğer hastalar hastalık düzenleyici anti-romatizmal ilaçlardan iki veya üçünü kullanıyordu. Tüm hastaların HAQ ve DAS28 skorları hesaplandı. Hem hastaların hem de kontrollerin NOx, TBARS, SA ve SH düzeyleri ölçüldü. Bulgular: RA hastalarının SA düzeyleri kontrol grubuna göre istatistiksel olarak anlamlı derecede yüksekti. Her iki grupta da TBARS ve NOx düzeylerinin artmış, SH düzeylerinin azalmış olduğunu bulduk. Ancak bu bulgular istatistiksel anlamlılığa ulaşmıyordu. Spearman korelasyon analizi sonucunda serum TABRS düzeyleri ile hem NOx hem de SA düzeyleri arasında olumlu korelasyon olduğu ortaya çıktı (r=0,322, p=0,001) and SA (r=0,242, p=0,017). Sonuç: Bulgularımız SA’nın RA patogenezindeki rolünü ve oksidatif stresle ilişkisini desteklemektedir. RA tedavisinin serum oksidatif stres parametrelerine uzun dönem etkisini incelemeyi hedefleyen, daha geniş sayıda hastayla ve daha uzun süreli tedavi takibiyle yapılacak çalışmalara ihtiyaç bulunmaktadır.

🔖

Cite This Article

YÜKSEL, H., YILMAZ, G., ERER, B., ERER, B., YAZICI, S., YILMAZ, F. M. (2022). Anti-TNF-α ve geleneksel tedavi alan romatoid artritli hastalarda serum sialik asit ve oksidatif stres parametrelerinin değerlendirilmesi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 56 - Sayı: 4, 182–185. https://ajindex.com/articles/629055

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fox DA. Etiology and pathogenesis of rheumatoid arthritis. In: Koopman WJ, Moreland LW, editors. Arthritis and allied conditions: a textbook of rheumatology. 15th ed. Philadelphia: Lippincot Williams and Wilkins; 2005.p. 1089-115
  2. Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995;51:419-36
  3. Hitchon CA, El-Gabalawy H. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-78
  4. Tak PP, Zvaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000;21:78-82
  5. Zwerina J, Redlich K, Schett G, Smolen JS. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci 2005;1051:716-29
  6. Ridderstad A, Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med 1991;23:219-23
  7. Miesel R, Murphy MP, Kroger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 1996;25:161-9
  8. Schauer R. Sialic acids and their role as biological markers. Trends Biochem Sci 1985;10:357-60
  9. Taniuchi K, Chifu K, Hayashi N, Nakamachi Y, Yamaguchi N, Miyamato Y, et al. A new enzymatic method for the determination of sialic acid and its application as a marker of acute phase reactants. Kobe J Med Sci 1981;27:91-102
  10. Lindberg G, Eklund G, Gullberg B, Rastam L, Plater M, Ionescu-Tirgouiste C, et al. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991;302:143-6
  11. Watts GF, Crook MA, Haq S, Mandalia S. Serum sialic acid as an indicator of change in coronary artery disease. Metabolism 1995;44:147-8
  12. Knuiman MW, Watts GF, Divitini ML. Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia. Ann Epidemiol 2004;14:627-32
  13. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63
  14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
  15. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and vali